MRI-guided breast biopsy system is safe and efficient

May 05, 2004

It is now possible to safely and efficiently do a breast biopsy if a lesion is seen on MRI without sending the patient to surgery, a new study shows.

"In the past, if MRI detected a breast lesion, our only options would be to do a core biopsy or insert a wire in the area of the lesion; then the patient would have to go to surgery to have the lesion removed," said Constance Lehman, MD, PhD, associate professor of radiology and director of breast imaging at the University of Washington in Seattle. The vacuum assisted breast biopsy system, which has proven effective with mammography and ultrasound, can now quickly and accurately retrieve tissue under MRI-guidance, Dr. Lehman said.

Dr. Lehman reviewed 38 MRI-guided biopsies in 28 patients. "All of the biopsies were technically successful, and there were no complications associated with any of the procedures," Dr. Lehman said. The average time to perform the biopsies ranged from 38 minutes for single biopsies in a single breast to 64 minutes if performed on both breasts, she said. "The short time to do the biopsies is important both for patient comfort and so we can sample the tissue while the contrast-enhanced lesion is still visible," she said.

Most of the patients in the study had recently been diagnosed with breast cancer; MRI was being done on the breast that didn't have the cancer to determine the extent of cancer in the breast. They were women who were at high risk of breast cancer, or they had had a negative mammogram and/or a negative ultrasound examination, but their physician was still suspicious of the negative diagnosis, said Dr. Lehman.

"We are seeing an increase in the use of breast MRI, and we needed the means to accurately and successfully sample tissues seen only on MRI. This new method of vacuum-assisted breast biopsies is successfully providing that means," said Dr. Lehman.

Dr. Lehman will present her study on May 5 at the American Roentgen Ray Society Annual Meeting in Miami Beach, FL.
Keri J. Sperry 703-858-4306;703-919-8536
Jason Ocker 703-858-4304
Press Room 786-276-1351

American College of Radiology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to